Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-30

Clinical Trial Update: Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating atacicept in combination with rituximab in rheumatoid arthritis has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atacicept (atacicept)
  • Rituximab (rituximab)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-12-30